Protea Biosciences, Inc. Announces 2013 Year-End Results and Key Developments

MORGANTOWN W.Va., March 31, 2014 (GLOBE NEWSWIRE) -- Protea Biosciences Group, Inc. ("Protea") released its 2013 results today reporting total revenue for the fiscal year ended December 31, 2013 of $1.22 million. This represents a 47% increase over Protea's fiscal year 2012 total revenue and is the first fiscal year that total revenues exceeded $1.0 million. This increase in revenue is the result of sales of the Company's LAESI® instrument platform.

Help employers find you! Check out all the jobs and post your resume.